close

March 13, 2025

Crown Bioscience Appoints John Gu as Chief Executive Officer

February 17, 2025

Crown Bioscience Completes Merger with Indivumed Services

February 11, 2025

Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation

December 11, 2024

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

December 10, 2024

Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation

December 12, 2024

Translating In Vitro and In Vivo Multi-Omics Oncology Data to Enhance Early Biomarker Discovery

October 30, 2024

Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biopsy Test

October 1, 2024

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

August 21, 2024

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

May 24, 2024

Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center

May 23, 2024

Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies

Contact Us
Biospecimen Request
Databases
CrownLink

US Tel: +1 858 622 2900

UK Tel: +44 870 242 2900

All Contact Information

Our Services
Our Science
About Us
Contact us

Blog

Orthotopic Models (8)

In Vivo Imaging of Syngeneic Models for Immuno-Oncology Studies

5 minute read

In Vivo Imaging of Syngeneic Models for Immuno-Oncology Studies

November 6, 2020

Applications and Benefits of Engineered Syngeneic Cell Lines

3 minute read

Applications and Benefits of Engineered Syngeneic Cell Lines

October 26, 2020

Meet the CrownBio Team: Dr Marrit Putker, Organoid Research Scientist

4 minute read

Meet the CrownBio Team: Dr Marrit Putker, Organoid Research Scientist

October 21, 2020

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

5 minute read

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

October 14, 2020

T Cell Dysfunction Assays for In Vitro Screening of Immunomodulatory Drug Candidates

4 minute read

T Cell Dysfunction Assays for In Vitro Screening of Immunomodulatory Drug Candidates

September 22, 2020

Why Choose Tumor Organoids vs Other 3D In Vitro Models for Oncology Drug Development

4 minute read

Why Choose Tumor Organoids vs Other 3D In Vitro Models for Oncology Drug Development

August 20, 2020

Digital Pathology

7 minute read

Digital Pathology

July 23, 2020

Next Generation Sequencing 101

4 minute read

Next Generation Sequencing 101

July 16, 2020

Immunogenomics in Oncology Drug Development

6 minute read

Immunogenomics in Oncology Drug Development

July 10, 2020

Using Tumor Organoids to Identify Cancer Biomarkers

4 minute read

Using Tumor Organoids to Identify Cancer Biomarkers

June 8, 2020

View Recent Posts View Older Posts

Search our Blog

Categories

About Us

Our Company
Our Purpose
Our Responsibility
Leadership
News & Events

Our Services

Platforms
Target Solutions
Technologies
Service Type

Resources

Blog
Preclinical Models
Publications
Factsheets
White Papers
Ebooks
Webinars

Platforms

OncoExpress™
XenoBase®
MuBase®
HuBase™
OrganoidBase™
CrownLink™

Talk To Us

+1 858 381 3547
Contact Us
Distributors
LinkedIn
X

© 2025 Crown Bioscience. All Rights Reserved.

Privacy Policy | Imprint | Terms of Service | Privacy Preferences

© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy

2025-03-03

2022-12-16